AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Halozyme TherapeuticsAllogene Therapeuticsbluebird bioCrispr TherapeuticsAudentes Therapeutics
SymbolNASDAQ:HALONASDAQ:ALLONASDAQ:BLUENASDAQ:CRSPNASDAQ:BOLD
Price Information
Current Price$24.10$48.92$63.09$63.72$59.97
52 Week RangeBuyBuyBuyBuyHold
Beat the Market™ Rank
Overall Score2.21.31.61.40.9
Analysis Score3.42.34.43.41.1
Community Score2.62.33.02.52.6
Dividend Score0.00.00.00.00.0
Ownership Score3.02.00.01.01.0
Earnings & Valuation Score1.90.00.60.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$28.63$39.09$115.47$74.42$50.75
% Upside from Price Target18.78% upside-20.09% downside83.02% upside16.80% upside-15.37% downside
Trade Information
Market Cap$3.29 billion$6.19 billion$3.56 billion$3.89 billion$2.77 billion
Beta1.751.72.382.262.18
Average Volume1,526,6711,566,5851,796,3651,019,7411,504,389
Sales & Book Value
Annual Revenue$195.99 millionN/A$44.67 million$289.59 millionN/A
Price / Sales16.70N/A78.6013.43N/A
CashflowN/AN/AN/A$1.25 per shareN/A
Price / CashN/AN/AN/A51.15N/A
Book Value$0.43 per share$4.84 per share$20.13 per share$14.52 per share($7.48) per share
Price / Book56.05N/A3.134.39N/A
Profitability
Net Income$-72,240,000.00$-184,590,000.00$-789,610,000.00$66.86 million$-128,820,000.00
EPS($0.50)($1.83)($14.31)$1.17($3.40)
Trailing P/E RatioN/AN/AN/A84.96N/A
Forward P/E Ratio15.45N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-48.75%N/A-1,531.04%15.73%N/A
Return on Equity (ROE)-48.92%-33.05%-60.05%6.54%N/A
Return on Assets (ROA)-17.36%-29.27%-46.17%5.54%-38.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio6.66%0.08%0.16%N/AN/A
Current Ratio11.14%18.81%5.25%16.87%12.80%
Quick Ratio10.15%18.81%5.25%16.87%12.79%
Ownership Information
Institutional Ownership Percentage95.37%57.93%N/A57.96%96.33%
Insider Ownership Percentage2.60%36.50%3.00%21.40%5.30%
Miscellaneous
Employees2811221,090188207
Shares Outstanding135.82 million125.33 million55.65 million61.02 million46.27 million
Next Earnings Date8/4/2020 (Estimated)8/5/2020 (Estimated)8/6/2020 (Estimated)8/3/2020 (Estimated)N/A
OptionableOptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.